Logo image of ALCAR.PA

CARMAT (ALCAR.PA) Stock Fundamental Analysis

EPA:ALCAR - Euronext Paris - Matif - FR0010907956 - Common Stock - Currency: EUR

0.806  0 (-0.25%)

Fundamental Rating

2

ALCAR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALCAR have multiple concerns. ALCAR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALCAR has reported negative net income.
In the past year ALCAR has reported a negative cash flow from operations.
In the past 5 years ALCAR always reported negative net income.
In the past 5 years ALCAR always reported negative operating cash flow.
ALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

ALCAR has a Return On Assets of -121.13%. This is amonst the worse of the industry: ALCAR underperforms 91.53% of its industry peers.
Industry RankSector Rank
ROA -121.13%
ROE N/A
ROIC N/A
ROA(3y)-95.2%
ROA(5y)-87.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAR.PA Yearly ROA, ROE, ROICALCAR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

ALCAR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCAR.PA Yearly Profit, Operating, Gross MarginsALCAR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

ALCAR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALCAR has more shares outstanding
Compared to 5 years ago, ALCAR has more shares outstanding
Compared to 1 year ago, ALCAR has a worse debt to assets ratio.
ALCAR.PA Yearly Shares OutstandingALCAR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ALCAR.PA Yearly Total Debt VS Total AssetsALCAR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -5.98, we must say that ALCAR is in the distress zone and has some risk of bankruptcy.
ALCAR has a Altman-Z score of -5.98. This is amonst the worse of the industry: ALCAR underperforms 86.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.98
ROIC/WACCN/A
WACC6.66%
ALCAR.PA Yearly LT Debt VS Equity VS FCFALCAR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

2.3 Liquidity

A Current Ratio of 2.60 indicates that ALCAR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.60, ALCAR is in the better half of the industry, outperforming 72.88% of the companies in the same industry.
ALCAR has a Quick Ratio of 1.01. This is a normal value and indicates that ALCAR is financially healthy and should not expect problems in meeting its short term obligations.
ALCAR's Quick ratio of 1.01 is in line compared to the rest of the industry. ALCAR outperforms 44.07% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.01
ALCAR.PA Yearly Current Assets VS Current LiabilitesALCAR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.50% over the past year.
ALCAR shows a strong growth in Revenue. In the last year, the Revenue has grown by 149.16%.
ALCAR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 46.22% yearly.
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
Revenue 1Y (TTM)149.16%
Revenue growth 3Y46.22%
Revenue growth 5YN/A
Sales Q2Q%64.17%

3.2 Future

The Earnings Per Share is expected to grow by 40.13% on average over the next years. This is a very strong growth
ALCAR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 243.80% yearly.
EPS Next Y56.82%
EPS Next 2Y30.23%
EPS Next 3Y40.13%
EPS Next 5YN/A
Revenue Next Year103.8%
Revenue Next 2Y137.66%
Revenue Next 3Y243.8%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALCAR.PA Yearly Revenue VS EstimatesALCAR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
ALCAR.PA Yearly EPS VS EstimatesALCAR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALCAR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALCAR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAR.PA Price Earnings VS Forward Price EarningsALCAR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAR.PA Per share dataALCAR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

ALCAR's earnings are expected to grow with 40.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.23%
EPS Next 3Y40.13%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCAR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARMAT

EPA:ALCAR (6/17/2025, 7:00:00 PM)

0.806

0 (-0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)09-10 2025-09-10
Inst Owners0.53%
Inst Owner ChangeN/A
Ins Owners23.06%
Ins Owner ChangeN/A
Market Cap47.41M
Analysts84.29
Price Target3.74 (364.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.92%
PT rev (3m)-20.58%
EPS NQ rev (1m)18.52%
EPS NQ rev (3m)18.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.81%
Revenue NQ rev (1m)-31.43%
Revenue NQ rev (3m)-31.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.8
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.21
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0.12
BVpS-0.58
TBVpS-0.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -121.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-95.2%
ROA(5y)-87.39%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.85%
Cap/Sales 21.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.01
Altman-Z -5.98
F-Score3
WACC6.66%
ROIC/WACCN/A
Cap/Depr(3y)22.04%
Cap/Depr(5y)20.77%
Cap/Sales(3y)259.4%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.95%
EPS Next Y56.82%
EPS Next 2Y30.23%
EPS Next 3Y40.13%
EPS Next 5YN/A
Revenue 1Y (TTM)149.16%
Revenue growth 3Y46.22%
Revenue growth 5YN/A
Sales Q2Q%64.17%
Revenue Next Year103.8%
Revenue Next 2Y137.66%
Revenue Next 3Y243.8%
Revenue Next 5YN/A
EBIT growth 1Y6.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year19.27%
EBIT Next 3Y23.36%
EBIT Next 5YN/A
FCF growth 1Y23.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.01%
OCF growth 3YN/A
OCF growth 5YN/A